Addressing the Digital Divide—mHealth in Cancer Care

Published Nov 8, 2017
Glasgow, Scotland, UK—8 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), held an issue panel this afternoon that focused on mHealth in cancer care at its 20th Annual European Congress in Glasgow, Scotland, UK. The issue panel, “mHealth Among Clinicians and Patients in Cancer Care: How to Address the Digital Divide” [IP26], was moderated by Rosanna Tarricone, PhD, Bocconi University, Milan, Italy. Panelists included Maria Cucciniello, PhD, Bocconi University, Milan, Italy; Roma Maguire, PhD, MSc, University of Surrey, Glasgow, UK; and Nicola Scalzo, MSc, European Commission, Brussels, Belgium. The use of mobile technologies in health care—mHealth—is surging in cancer care; however, its potential has yet to be fully explored. The panel reviewed mHealth’s use in cancer care today, explored its potential, and discussed the barriers that currently prevent greater utilization. Maria Cucciniello, PhD discussed the results of an international survey on the use of mHealth that included the determinants that explain differences in uptake rates. Roma Maguire, PhD, MSc offered an overview of the potential mHealth has to empower patients and facilitate symptom management. Nicola Scalzo, MSc provided a regulatory perspective on mHealth and commented on how the newly adopted European Union regulation on medical devices may impact mHealth. Additional information on the ISPOR 20th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the congress on social media using the hashtag #ISPORGlasgow.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×